SOUTH AFRICA

Bovishield® FP 4 + L5

Reg No. G3359 (Act 36/1947) – Vet Only

Bovi-Shield® FP 4+L5 is a freeze-dried preparation of modified live virus (MLV) strain of IBR, BVD, PI3 and BRSV viruses, plus a liquid bacterin containing the 5 Leptospira serovars, identified above.

Expand All
    • Infectious Bovine Rhinotracheitis (IBR) virus.
    • Bovine Viral Diarrhoea (BVD Type 1 and 2).
    • Parainfluenza 3 (PI3).
    • Bovine Respiratory Syncytial Virus (BRSV).
    • Leptospira canicola, L. grippotyphosa, L.hardjo, L.icterohaemorrhagiae, and L.pomona.
    • Trusted and proven modified-live vaccine protection for respiratory and reproductive diseases caused by IBR, BVD (Type 1 and Type 2), PI3 and BRSV.
    • BOVI-SHIELD FP provides cattle with the most comprehensive fetal protection against reproductive and viral respiratory diseases, including persistent infection (PI) caused by BVD Type 1 or Type 2.
    • A modified-live vaccine, BOVI-SHIELD FP stimulates killer T cells in the body, providing important cell-mediated immunity, which aids in the prevention of IBR abortion.
    • BOVI-SHIELD FP 4+L5 is proven to help protect against Leptospira.
    • Vaccinating pregnant cows with BOVI-SHIELD FP 4+L5, when used according to label, has been proven safe and can help boost antibody levels in the dam’s colostrum, building the calf’s immune system even before it is born and preparing it for disease challenge at birth.
    • Vaccinating nursing calves with BOVI-SHIELD FP 4+L5 is a safe and effective way to protect calves prior to peak stress, without risking the pregnancy of their dams, if used according to label direction.
    • Bovi-Shield® FP 4+L5 is recommended for vaccination of healthy cows and heifers prior to breeding as an aid in preventing abortion caused by infectious Bovine virus diarrhea (BVD) virus Type 1 and 2 and rhinotracheitis (IBR) bovine herpes-virus Type I virus; persistent calf infection caused by bovine virus diarrhea (BVD) virus Type 1 and 2; respiratory disease caused by IBR, BVD Type 1 and 2, para-influenza3 (PI3) and bovine respiratory syncytial virus (BRSV); and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L.hardjo, L.icterohaemorrhagiae, and L.pomona.
    • Administer a single 2ml dose to healthy cattle, followed by a booster dose of Bovi-Shield FP 4+L5, four weeks later.
    • Annual revaccination with a single dose of Bovi-Shield® FP 4+L5 is recommended.
    • Do not slaughter cows for human consumption within 21 days after vaccination.
    • Do not use in pregnant cows (abortion can result) unless they were vaccinated prior to breeding with Bovi Shield FP4 + L5.
    • Keep out of reach of children and uninformed persons.
    • Store at 2 - 7°C. Protect from heat and light.
    • Bovi-Shield® FP 4+L5 is marketed in clear, sterile and sealed 10 and 50 dose vials. One vial Bovi-Shield® FP4 and one vial Leptoferm-5® + A per carton.

DISCLAIMER: ALTHOUGH GREAT CARE HAS BEEN TAKEN IN THE COMPILATION OF THIS DOCUMENT, READERS ARE REQUESTED TO REFER TO THE PACKAGE INSERT FOR COMPLETE DETAILS BEFORE USING THE SPECIFIC PRODUCT.